Article Text

PDF
Original research
Pial arteriovenous fistulae in pediatric patients: associated syndromes and treatment outcome
  1. Brian P Walcott1,
  2. Edward R Smith2,
  3. R Michael Scott2,
  4. Darren B Orbach3
  1. 1Department of Neurosurgery, Massachusetts General Hospital, Boston, Massachusetts, USA
  2. 2Department of Neurosurgery, Children's Hospital Boston, Boston, Massachusetts, USA
  3. 3Department of Neurointerventional Radiology, Children's Hospital Boston, Boston, Massachusetts, USA
  1. Correspondence to Dr Darren B Orbach, Neurointerventional Radiology, Children's Hospital Boston, 300 Longwood Avenue, Boston, MA 02115, USA; darren.orbach{at}childrens.harvard.edu

Abstract

Objective Pediatric pial arteriovenous fistulae (pAVF) are rare vascular lesions of the CNS, reported to have up to a 25% association with hereditary hemorrhagic telangiectasia. The presentation, treatment and syndromes associated with pAVF in children are reported here.

Design A pediatric database for pAVF was retrospectively reviewed. Patients with carotid–cavernous fistulae, dural arteriovenous fistulae, brain arteriovenous malformations and vein of Galen malformations were excluded. Radiographic outcome was assessed using digital subtraction angiography, and clinical outcome by the Functional Status Scale (6=normal, maximal incapacity=30).

Results Between July 2003 and June 2011, seven patients with pAVF (six intracranial and one spinal) were treated. Mean age was 4.2 years. The most common clinical presentation was high output cardiac failure (43%). Two patients (29%) harbored a known mutation in the RASA1 gene, associated with a hereditary vascular syndrome: capillary malformation–arteriovenous malformation. No patient had hereditary hemorrhagic telangiectasia. Treatment resulted in complete lesional obliteration in six of seven patients, with treatment ongoing in the seventh. Five of seven patients had combined endovascular and surgical treatment while two underwent endovascular embolization alone. Functional Status Scale scores at the most recent follow-up were 6 in all but one patient who had presented with a pretreatment hemianopsia.

Conclusion Treatment is effective in obliterating pAVF in children, with an excellent prognosis seen in our cohort. Genetic screening is indicated, with capillary malformation–arteriovenous malformation being the most frequently seen syndrome. No patients had hemorrhagic hereditary telangiectasia.

Statistics from Altmetric.com

Footnotes

  • Competing interests None.

  • Ethics approval The study was approved by the Children's Hospital Boston institutional review board.

  • Provenance and peer review Not commissioned; externally peer reviewed.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Linked Articles